De wittenskip efter lang libjen: wat wy yn 2026 witte
August 5, 2026 · Frisian News
The longevity industry raises billions to develop drugs that work in mice but fail in humans. The honest truth: we don't yet know how to extend human lifespan.
FryskDe biotechindustry foar lang libjen helle ferline jier 5 miljard op, mar hast elk medisyn dat ferâldering by mûzen omkeart, mislearret by minsken. Ûndersikers testje al desennia lang middels tsjin selferâldering, NAD+-paden en aaiwit-folding. De kleau tusken de labmûs en de libbende mins bliuwt like grut.
Wa besit dizze bedriuwen? Foaral Silicon Valley-weagkapitaal en techmiljarders. Sy finansearje it ûndersyk, hiere de bêste wittenskippers, en hâlde de patenten fêst. Soe immen minsklik lang libjen krake, dan meitsje de patenten in pear minsken skandalich ryk. En de behannelingen koste mear as wat de measte minsken yn in jier fertsjinje.
De earlike wittenskip seit: wy witte it net. Wy kinne ferâldering by minsken net fertrage. NAD+-boosters toane belofte by mûzen en yn swakke stúdzjes by minsken. Senolytika romden âlde sellen yn guon proeven op, mar nimmen libbe langer. Wy witte net iens oft it fuortsmiten fan âlde sellen it libben ferlinget of sellen allinne jonger makket yn in petriskaal.
Wat wurket, is saai. Kalorjebeheining ferlinget it libben by bisten en inkele minsklike merkers sjogge der better út. Beweging bout spieren en bonken. Sliep docht derta. Gjin miljardêr ynvestearre yn in middel foar 'mear sliepe' om't der gjin patent is, gjin winst.
De langdurige yndustry wol dy ivige jeugd ferkeapje. Foar no ferkeapje se dy hoop en djoere supplements. De wittenskip sil der úteinlik komme. Mar net op 'e tiid foar wa't it finansiert.
The longevity biotech industry raised $5 billion last year, yet almost every drug that reverses aging in mice has failed in humans. Researchers tested compounds targeting cellular senescence, NAD+ pathways, and protein folding for decades now. The gap between lab mouse and living person remains as wide as ever.
Who owns these companies? Mostly Silicon Valley venture capital and tech billionaires. They fund the research, hire the best scientists, and hold the patents. If someone does crack human longevity, the patents will make a few people obscenely rich. And the treatments will cost more than most people earn in a year.
The honest science says we don't know yet. We can't slow aging in humans. NAD+ boosters show promise in mice and weak human studies. Senolytics cleared senescent cells in some trials but no one has lived longer. We don't even know if removing old cells extends life or just makes cells younger in the petri dish.
What we know works is boring. Caloric restriction extends life in animals and some human markers look better. Exercise builds muscle and bone. Sleep matters. No billionaire invested in a compound for "sleep more" because there's no patent, no profit.
The longevity industry wants to sell you eternal youth. For now they're selling you hope and expensive supplements. The science will get there eventually. Just not in time for the people funding it.
Published August 5, 2026 · Frisian News · Ljouwert, Fryslân